Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation
NCT ID: NCT02541266
Last Updated: 2020-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
207 participants
OBSERVATIONAL
2015-04-01
2018-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Imaging NSCLC Treatment Response to Immunotherapy
NCT02753569
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713
PET/MR in Radiotherapy for Head and Neck Cancer Pilot
NCT02952625
PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma
NCT00943423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Patients currently recruited to studies with imaging at The Marsden
Questionnaire
A short questionnaire (9 questions) will be given to the participants to complete.
Group 2
Patients who have previously participated in studies with imaging at The Marsden
Questionnaire
A short questionnaire (9 questions) will be given to the participants to complete.
Group 3
Patients attending for scans as part of their clinical pathway
Questionnaire
A short questionnaire (9 questions) will be given to the participants to complete.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
A short questionnaire (9 questions) will be given to the participants to complete.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over the age of 18
* Having imaging (MRI or PET/CT) as part of research or clinical care.
* Group 1
* Currently enrolled in a research project that involves imaging (either MRI or PET/CT)
* Group 2
* Previously enrolled in a research project that involved imaging (either MRI or PET/CT), where the patients involvement in the research project has now ended.
* Group 3
* Patients attending the MRI or PET/CT departments for imaging as part of their standard clinical care.
Exclusion Criteria
* Previously completed questionnaire.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute for Health Research, United Kingdom
OTHER_GOV
Royal Marsden NHS Foundation Trust
OTHER
Institute of Cancer Research, United Kingdom
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nandita deSouza
Professor of Translational Imaging
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15 LO 1189
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.